ACRV·004890109·US·equity·Healthcare - Biotechnology-Activist
ACRV (Acrivon Therapeutics, Inc.) is held by 37 institutional investors as of Q4 2025. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($20.1M), CITADEL ADVISORS LLC ($4M), WELLINGTON MANAGEMENT GROUP LLP ($2.1M). Net institutional sentiment: Mixed.
See how ACRV's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer